ALX Oncology Holdings Inc.

NasdaqGS:ALXO Stock Report

Market Cap: US$74.4m

ALX Oncology Holdings Dividends and Buybacks

Dividend criteria checks 0/6

ALX Oncology Holdings does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-82.2%

Buyback Yield

Total Shareholder Yield-82.2%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

ALX Oncology's Evorpacept Gains Momentum With FDA Fast Track Designations

Sep 12

ALX Oncology: Finally Reaching A Reasonable Buy-In Valuation

Jun 27

ALX Oncology: Trying To Justify The Hype

Apr 18

Is ALX Oncology Holdings (NASDAQ:ALXO) Using Debt In A Risky Way?

Mar 12
Is ALX Oncology Holdings (NASDAQ:ALXO) Using Debt In A Risky Way?

ALX Oncology GAAP EPS of -$0.81 misses by $0.18

Aug 08

ALX Oncology stock rises on FDA fast track status for evorpacept to treat head/neck cancer

Aug 01

ALX Oncology stock rises 14% on evorpacept's FDA orphan drug status for blood cancer

Jun 29

ALX Oncology Is Turning Into An Also-Ran In Anti-CD47

Feb 15

ALX Oncology Stock: Attractive After Recent Data And Slump In Price

Nov 30

ALX Oncology Is The Next CD47 Biotech To Watch After Recent Acquisitions In This Space

Sep 08

Here's Why We're Not Too Worried About ALX Oncology Holdings' (NASDAQ:ALXO) Cash Burn Situation

Jul 08
Here's Why We're Not Too Worried About ALX Oncology Holdings' (NASDAQ:ALXO) Cash Burn Situation

Dosing underway in ALX Oncology's ALX148 combo study in head and neck cancer

May 10

We're Not Very Worried About ALX Oncology Holdings' (NASDAQ:ALXO) Cash Burn Rate

Mar 25
We're Not Very Worried About ALX Oncology Holdings' (NASDAQ:ALXO) Cash Burn Rate

Here's What ALX Oncology Holdings Inc.'s (NASDAQ:ALXO) Shareholder Ownership Structure Looks Like

Feb 01
Here's What ALX Oncology Holdings Inc.'s (NASDAQ:ALXO) Shareholder Ownership Structure Looks Like

ALX Oncology: All Their Eggs In The Proverbial Basket

Jan 07

ALX Oncology (ALXO) Presents At 62nd Virtual Annual Meeting of ASH - Slideshow

Dec 11

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ALXO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALXO's dividend payments have been increasing.


Dividend Yield vs Market

ALX Oncology Holdings Dividend Yield vs Market
How does ALXO dividend yield compare to the market?
SegmentDividend Yield
Company (ALXO)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Biotechs)2.3%
Analyst forecast (ALXO) (up to 3 years)0%

Notable Dividend: Unable to evaluate ALXO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ALXO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ALXO's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ALXO has not reported any payouts.


Discover strong dividend paying companies